The RepTrak Company

Reputation is not a static benchmark. It’s an ever-evolving asset that must be actively managed. The one constant industries can rely on is change. For companies aiming to succeed, developing a long-term reputation strategy is essential. Your corporate reputation is built on the perceptions of stakeholders. And if you’re not actively working to build it, someone else will do it for you. ➡️ Businesses that prioritize reputation management today are setting themselves up to thrive both now and in the future. Trust and credibility form the foundation of sustainable growth and companies that invest in these areas are better positioned to turn positive perceptions into concrete business outcomes. At RepTrak, we bridge the gap between perception and reality, transforming reputation into a measurable, actionable asset. Request a demo today: https://lnkd.in/g6pYZBJC

Perceptions of your industry don’t exist in isolation — they drive real actions. RepTrak’s Business Outcomes measure the actions stakeholders are willing to take when considering, supporting or engaging with your company. From recommending products to trusting you, Business Outcomes provide crucial insight into the behaviors of Pharma’s stakeholders (patients, healthcare professionals, investors, regulators, and more). These Scores reveal the “so what?” behind your Reputation Score showing the real-world impact on stakeholder engagement. By tracking these metrics, companies can: ✅ turn critics into advocates ✅ benchmark performance against competitors ✅ maintain strong relationships with key stakeholders Understanding Business Outcomes is essential, especially for Pharma companies that rely so much on building trust and credibility. If you’re ready to be a force in the industry, RepTrak for Pharma is here to help. Our tailored industry offerings help Pharma companies navigate critical reputation insights and pair them with actionable intelligence. Learn more at: https://lnkd.in/g_4ZEHHP

Generic data isn't enough to properly manage your corporate reputation. To thrive, businesses need sector-specific intelligence and expert guidance — and that’s exactly what RepTrak for Industry delivers. Across 30+ industries, RepTrak equips companies with actionable insights to build trust, manage risk, and drive measurable results. From regulatory compliance in Pharma, to customer engagement in Retail, our dedicated advisors and customized data are tailored to your unique challenges. Manage your entire reputation strategy in one platform, streamline decision-making, and stay ahead in an ever-changing market. Learn more about RepTrak for Industry: https://lnkd.in/e5AvTviJ

Managing corporate reputation effectively requires more than just data, it calls for expert guidance and actionable strategies. That’s where RepTrak's Advisory Insights comes in. Our innovative feature connects you directly with our seasoned advisory team, bringing a personalized touch to your reputation management. Whether it’s tailored advice on mitigating potential risks or managing a crisis, Advisory Insights gives you the expert guidance you need to maintain a strong reputation: ✅ Tailored stakeholder insights ✅ Actionable guidance ✅ Advisory library to access all your reports The best thing? You can manage all aspects of your reputation strategy from one central location, streamlining your processes and enhancing your ability to respond quickly to emerging challenges and opportunities. See why corporate communicators love this tool 🫶: https://lnkd.in/dPzQTEEK 

Pharma’s role in society is expanding 🌏 It’s no longer just about healing bodies, Pharma's role now extends to making broader contributions to general welfare. RepTrak’s Citizenship Driver measures a company’s efforts in making the world a better place — and stakeholders are paying attention. In H1 2024, Pharma’s Citizenship Score rose to 70.8, reflecting the industry's growing commitment to making a positive impact on society. Whether it's supporting good causes or promoting environmental sustainability, stakeholders now expect Pharma to help address other global challenges, not just pandemics. Consumers, in particular, are looking to Pharma to be a champion of holistic health. This convergence of sustainable wellness, holistic medicine, and preventative care puts further pressure on Pharma to act as a global corporate citizen, driving change in medicine and in the well-being of everyday life. By embracing these responsibilities, Pharma can foster greater trust and strengthen its reputation as a force for good in the world. If you’re ready to be a force in the industry, RepTrak for Pharma is here to help. Our tailored industry offerings help Pharma companies navigate critical reputation insights, and pair them with actionable intelligence. Learn more at: https://lnkd.in/g_4ZEHHP

Pharma’s recent reputational boost offers a chance for companies to build lasting trust — but how do you make it stick? 👥 Nathália Porto, Director of Advisory (Americas) at RepTrak, explains that it’s all about connecting with stakeholders: “Beyond expertise and compliance, Pharma companies need to build trust through proximity — positioning themselves as a trusted partner in stakeholders’ everyday health challenges and developing engagement efforts that actively drive consumer loyalty.” "A expertise e o respeito às regras do jogo no ambiente de negócios não são mais suficientes para alimentar a confiança do público nas empresas do setor Farmacêutico. As empresas devem trabalhar também sua proximidade às audiências, posicionando-se como parceiras ativas na jornada de melhoria da saúde das pessoas e engajando-as ativamente para garantir sua fidelidade como consumidores.” It’s about more than just meeting standards — it’s about becoming an essential part of everyday life. When Pharma companies work with RepTrak, they get paired with a team of industry-expert advisors. They’ll work you to interpret your reputation data, and work towards reputational growth. Discover more of our RepTrak for Pharma solutions: https://lnkd.in/g_4ZEHHP 

In 2024, Pharma’s Reputation Score climbed into the Strong range following a promising 🔼 0.8-point increase. This upward shift signals a recovery for Pharma companies post-pandemic. However, RepTrak data reveals that while stakeholders are more inclined to trust Pharma companies to do the right thing, they’re not ready to give them the benefit of the doubt following a crisis.  Our new quick-slides reviews the latest trends for Pharma's reputation with actionable strategies to sustain and enhance stakeholder perceptions. As part of our expansive industry suite, RepTrak’s solutions for Pharma deliver customized strategic insights that empower Pharma companies to meet evolving stakeholder expectations with long-term reputation strategies. See how RepTrak can help: https://lnkd.in/g_4ZEHHP 

Trust and reputation are not the same thing 🙅♂️ Some reputation management companies may say that they are synonymous — but 20+ years of reputation monitoring have taught us that while trust and reputation are indeed connected, you need to measure and monitor them both. At RepTrak, we help Pharma companies navigate these delicate differences, so they can stand out as leaders in their industry. Our model quantifies how people feel, think, and act toward companies (and industries) globally. The Reputation Score reflects the emotional connection (the ‘‘feel’’) stakeholders have with companies. While Trust, on the other hand, is a stakeholder action measured in the suite of our Business Outcomes. These Outcomes measure the actions stakeholders are willing to take when supporting or engaging with a company. Despite the challenges Pharma has faced, the sector’s overall reputational health is on the mend. In H1 2024, Pharma’s Reputation Score stands at a Strong 70.2, while Trust To Do The Right Thing is at an Average 68.5. This means that while stakeholders have growing positive feelings towards Pharma, they’re less likely to trust them when an issue arises. ➡️ Companies that invest in a strategy that includes Reputation and Trust will be more likely to turn positive perceptions into consumer actions. At RepTrak, we understand the unique challenges and opportunities within the Pharmaceutical industry, which is why we've developed RepTrak for Pharma — a solution specifically tailored to help Pharma companies navigate the complexities between Trust and Reputation. Learn more about RepTrak for Pharma: https://lnkd.in/g_4ZEHHP 

Has Pharma's credibility improved since the pandemic? 💉😷 As the industry faces tighter restrictions worldwide, stakeholders are paying close attention to whether Pharma adheres to ethical practices and acts with transparency. This is where our Conduct Driver comes in. Conduct is one of our seven Drivers reflecting how stakeholders think about Pharma's fairness, ethicality, and transparency — 3 essential factors for cultivating credibility. According to the 2024 Pharma report, Pharma's Conduct Score has seen improvement, moving into the Strong range with an exact score of 70.0 ( 🔼  1.4 points). However, it remains the lowest of all seven Drivers. This highlights the continued pressure on Pharma to not only meet the standards of growing regulations but to operate under them in an increasingly scrutinized environment. Having good conduct is no longer just about compliance — it requires a well-rounded strategy that prioritizes stakeholders and their concerns.  Want to learn more about how Pharma can improve their reputation? https://lnkd.in/g_4ZEHHP